Status:
COMPLETED
Provocation of Freezing of Gait in Parkinson's Disease
Lead Sponsor:
University of Toronto
Conditions:
Parkinson Disease
Freezing of Gait
Eligibility:
All Genders
20-85 years
Phase:
NA
Brief Summary
Sample Size N= 10 Parkinson's disease patients with self-reported freezing of gait and 10 without self-reported freezing of gait (in total, 20 Parkinson's disease patients) Accrual Period Single visi...
Eligibility Criteria
Inclusion
- Idiopathic Parkinson's disease
- Hoehn \& Yahr Stage 1-3
- Ten with self-reported freezing of gait (score of 1 in part 1 of new freezing of gait questionnaire), and 10 without FOG..
- Sequence effect on feet (as score of at least 2 in the leg agility (item#3.8) of Movement Disorders Society-Unified Parkinson's disease rating scale part 3)
- Stable clinical response to medications or stimulation parameters for at least 1 months
- Able to walk on a motor-driven treadmill
- Ability to provide informed consent
Exclusion
- Severe imbalance that limits ambulation (Hoehn \&Yahr score above 4)
- Orthostatic hypotension
- Orthopedic conditions and other systemic disease affecting locomotion
- Shortness of breath and cardiac disease
- Psychiatric disorders needing medication
- Dementia
- Presence of other neurological disorder
Key Trial Info
Start Date :
March 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04799613
Start Date
March 15 2021
End Date
June 15 2022
Last Update
July 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto Western Hospital
Toronto, Ontario, Canada, M5T 2S8